Hypersensitivity and Performance status decreased
Summary:
Performance status decreased is found among people with Hypersensitivity, especially for people who are male, 20-29 old.
The study analyzes which people have Performance status decreased with Hypersensitivity. It is created by eHealthMe based on reports of 23 people who have Hypersensitivity from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Hypersensitivity?
Hypersensitivity is found to be associated with 2,751 drugs and 2,913 conditions by eHealthMe. Check the latest studies of Hypersensitivity.
What is Performance status decreased?
Performance status decreased is found to be associated with 515 drugs and 636 conditions by eHealthMe. Check the latest studies of Performance status decreased.
23 people who have Hypersensitivity and Performance Status Decreased are studied.

Gender of people who have Hypersensitivity and experienced Performance Status Decreased *:
- female: 35 %
- male: 65 %
Age of people who have Hypersensitivity and experienced Performance Status Decreased *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 12.5 %
- 20-29: 56.25 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 31.25 %
Common co-existing conditions for these people *:
- Ejaculation Disorder: 9 people, 39.13%
- Insomnia (sleeplessness): 3 people, 13.04%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 8.70%
- Headache (pain in head): 2 people, 8.70%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 8.70%
- High Blood Pressure: 2 people, 8.70%
- Pain: 2 people, 8.70%
- Constipation: 2 people, 8.70%
- Depression: 2 people, 8.70%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 8.70%
Common drugs taken by these people *:
- Sertraline: 8 people, 34.78%
- Zyrtec: 3 people, 13.04%
- Claritin: 3 people, 13.04%
- Xyrem: 2 people, 8.70%
- Vyvanse: 2 people, 8.70%
- Allegra: 2 people, 8.70%
- Ambien: 2 people, 8.70%
- Benadryl: 2 people, 8.70%
- Caplyta: 1 person, 4.35%
- Dapagliflozin: 1 person, 4.35%
Common symptoms for these people *:
- Headache (pain in head): 13 people, 56.52%
- Diarrhea: 11 people, 47.83%
- Weakness: 10 people, 43.48%
- Malaise (a feeling of general discomfort or uneasiness): 10 people, 43.48%
- Hot Flush (sudden feelings of heat): 9 people, 39.13%
- Circulatory Collapse: 9 people, 39.13%
- Hyperhidrosis (abnormally increased sweating): 9 people, 39.13%
- Loss Of Consciousness: 9 people, 39.13%
- Tremor (trembling or shaking movements in one or more parts of your body): 9 people, 39.13%
- Muscle Aches (muscle pain): 9 people, 39.13%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Performance status decreased?
- Check whether Performance status decreased is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Hypersensitivity (272,618 reports)
- Performance status decreased (5,418 reports)
All the drugs that are associated with Performance status decreased:
- Performance status decreased (515 drugs)
All the conditions that are associated with Performance status decreased:
- Performance status decreased (636 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Performance status decreased and Hypersensitivity, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Meclizine cause Dermatitis Diaper? - now
- Could Kuvan cause Hypotension? - 11 seconds ago
- Could Dexedrine cause Taste - Impaired? - 13 seconds ago
- Drug interactions of Mucinex D and Pataday - 23 seconds ago
- Could Digoxin cause Erection Problems? - 34 seconds ago
- Could Pantoprazole Sodium cause Pleuritic Pain? - 45 seconds ago
- Drug interactions of Magnesium Aspartate and Movicol - a minute ago
- Could Levaquin cause Anaphylaxis? - a minute ago
- Could Mounjaro cause Eczema? - a minute ago
- Could Mounjaro cause Dermatitis - Atopic? - a minute ago